首页> 外文期刊>Journal of Computer-Aided Molecular Design >Structure-based drug design, synthesis and biological assays of P-falciparum Atg3-Atg8 protein-protein interaction inhibitors
【24h】

Structure-based drug design, synthesis and biological assays of P-falciparum Atg3-Atg8 protein-protein interaction inhibitors

机译:P-Falciparum Atg3-ATG8蛋白质相互作用抑制剂的基于结构的药物设计,合成和生物学测定

获取原文
获取原文并翻译 | 示例
       

摘要

The proteins involved in the autophagy (Atg) pathway have recently been considered promising targets for the development of new antimalarial drugs. In particular, inhibitors of the protein-protein interaction (PPI) between Atg3 and Atg8 of Plasmodium falciparum retarded the blood- and liver-stages of parasite growth. In this paper, we used computational techniques to design a new class of peptidomimetics mimicking the Atg3 interaction motif, which were then synthesized by click-chemistry. Surface plasmon resonance has been employed to measure the ability of these compounds to inhibit the Atg3-Atg8 reciprocal protein-protein interaction. Moreover, P. falciparum growth inhibition in red blood cell cultures was evaluated as well as the cyto-toxicity of the compounds.
机译:涉及自噬(ATG)途径的蛋白质最近被认为是开发新的抗疟疾药物的有希望的目标。 特别地,ATG3和ATG8之间的蛋白质 - 蛋白质相互作用(PPI)的抑制剂是疟原虫的血浆生长的血液和肝阶段。 在本文中,我们使用计算技术来设计模拟ATG3相互作用基序的新类肽模拟,然后通过点击化学合成。 已经采用表面等离子体共振来测量这些化合物抑制ATG3-ATG8往复蛋白质 - 蛋白质相互作用的能力。 此外,评估了红细胞培养物中的P. falciparum生长抑制以及化合物的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号